Cancer is common because it is a fundamental risk of being a complex organism. Every time one of your roughly 37 trillion cells divides, its DNA must be copied, and errors inevitably slip through. Over a lifetime, those errors accumulate. Combined with longer lifespans, lifestyle shifts, and environmental exposures, the result is striking: an estimated 20 million new cancer cases were diagnosed worldwide in 2022, and that number is projected to reach 35 million by 2050.
Cancer Is Built Into How Our Bodies Work
Your body is a massive cooperative project. Trillions of cells follow shared genetic rules that tell them when to grow, when to stop, and when to die. Cancer happens when a cell breaks those rules. It starts dividing on its own terms, gaining a survival advantage at the expense of the organism. Biologists describe this as a form of “cheating” that undermines multicellular cooperation. It is not a modern invention or a failure of medicine. It is a trade-off that comes with having a complex body made of dividing cells.
Every normal cell accumulates mutations over time in a clock-like pattern. Most of these mutations are harmless. But occasionally, the right combination lands in genes that control growth or repair, and a cell begins its slide toward malignancy. Tumor cells typically carry three to four times more mutations than normal tissue in the same person. The process is largely random, which is why cancer can strike people who do everything “right” and spare people who don’t.
Aging Is the Biggest Single Risk Factor
The longer you live, the more time your cells have to accumulate DNA errors. This is why age is the most important risk factor for cancer overall. The numbers make the relationship clear: cancer occurs in fewer than 26 out of every 100,000 people under age 20. By ages 45 to 49, that climbs to about 350 per 100,000. Past age 60, it exceeds 1,000 per 100,000. The median age at diagnosis across all cancers is 67.
Different cancers cluster at different ages. Breast cancer has a median diagnosis age of 63, colorectal cancer 66, prostate cancer 68, and lung cancer 71. A few cancers, like bone cancer, peak in childhood, but these are exceptions. Roughly 1% of all cancers are diagnosed in children and adolescents. The overwhelming majority strike people in the second half of life, and because people around the world are living longer than ever, more of them are reaching the ages where cancer becomes likely. Globally, over 62% of all cancer cases in 2020 occurred in adults 60 and older, and that group’s cancer burden is expected to rise 75% by 2040.
Lifestyle Factors Drive 40% of U.S. Cases
About 40% of all cancers diagnosed in the United States are linked to modifiable risk factors: tobacco use, excess body weight, and alcohol consumption. Tobacco alone remains the leading preventable cause of cancer. Excess weight raises risk for at least 13 cancer types by altering hormone levels and promoting chronic inflammation. Alcohol damages DNA directly as the body metabolizes it.
These factors help explain why cancer rates shift as societies change. As countries adopt more sedentary habits, higher-calorie diets, and greater alcohol consumption, their cancer profiles start to resemble those of wealthier nations. Colorectal cancer is a clear example. Researchers have noted that reduced physical activity, rising obesity, and heavier drinking may be driving colorectal cancer rates higher in younger adults, particularly in countries undergoing rapid lifestyle transitions. The pattern suggests that a significant share of the global cancer burden is not fixed by biology but shaped by how people live.
Environmental Exposures Add Up Over Time
Air pollution, particularly fine particulate matter from burning fossil fuels, is an underappreciated contributor. A large study of Medicare beneficiaries in the U.S. found that for each incremental increase in long-term exposure to fine particulate matter, lung cancer incidence rose 6.4%, colorectal cancer 4.3%, prostate cancer 3.6%, and breast cancer 2.0%. Particles from fuel oil and coal combustion carried especially high risks, with lung cancer incidence jumping over 14% per unit increase in fuel oil pollution and colorectal cancer rising over 15%.
These are population-level effects, meaning millions of people breathing slightly dirtier air collectively produce thousands of additional cancer diagnoses each year. Industrial chemicals, ultraviolet radiation, and certain infections (like HPV and hepatitis B) add further layers of environmental risk that interact with the body’s own accumulation of cellular damage.
Only a Small Fraction Is Purely Inherited
Inherited gene mutations, the kind you’re born with and can pass to your children, account for up to 10% of all cancers. The rest arise from mutations that cells acquire during a person’s lifetime through the combination of normal copying errors, lifestyle exposures, and environmental damage described above. Even in families with a known genetic predisposition, cancer typically still requires additional acquired mutations to develop. Genetics loads the gun, but time and exposure pull the trigger in most cases.
Better Detection Finds More Cancer
Part of the reason cancer appears more common today is that we are far better at finding it. The introduction of screening mammography in the U.S. doubled the detection rate of early-stage breast cancer, from 112 to 234 cases per 100,000 women. Meanwhile, the rate of late-stage breast cancer dropped only modestly, from 102 to 94 per 100,000. That gap reveals something important: screening catches many small, early cancers that might never have been noticed in an earlier era. Some of these would have progressed, but others might have grown so slowly they would never have caused symptoms. The net effect is that screening inflates the total number of diagnosed cases, even when it doesn’t proportionally reduce advanced disease.
Similar patterns appear with prostate, thyroid, and kidney cancers, where wider use of imaging and blood tests has led to sharp increases in diagnoses without equivalent drops in death rates. This doesn’t mean screening is useless. It means that some of the rise in cancer numbers reflects our ability to detect disease, not necessarily a true increase in how often cancer develops.
More Survivors Mean More People Living With Cancer
Cancer prevalence, the total number of people alive who have ever been diagnosed, has nearly quadrupled in the U.S. since the mid-1970s. As of January 2022, an estimated 18.1 million Americans were living with a cancer diagnosis. This growth is driven by two forces: more people being diagnosed (due to aging and better detection) and more people surviving. Improvements in surgery, targeted therapies, and supportive care mean that many cancers diagnosed today are managed as chronic conditions rather than rapid death sentences.
The combination makes cancer seem omnipresent. You are more likely to know someone with cancer not only because more people get it, but because more people live years or decades after diagnosis. Both trends are expected to continue as populations age and treatments improve.
Why Rates Will Keep Rising
The WHO projects 35 million new cancer cases annually by 2050, a 77% increase over 2022 levels. The primary driver is demographics. The world’s population is growing and aging simultaneously, pushing more people into the age range where cancer risk is highest. In lower-income countries, urbanization is introducing the lifestyle risk factors that wealthier nations have dealt with for decades, while access to treatment and screening still lags behind. The result is a widening gap: more cancer diagnosed, but not always more capacity to treat it.
Cancer is common, in short, because it sits at the intersection of biology, time, and modern life. It is woven into the basic mechanics of cell division, amplified by the success of living longer, and shaped by the environments and habits that define contemporary society.